In the fiscal year 2022, the total number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan amounted to approximately 5.3 thousand. PMDA functions as a regulatory agency for pharmaceutical products and medical devices, working with Japan's health ministry.
Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2022, by type
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2022
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of quasi-drugs approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2022, by type
- Premium Statistic Number of NME approved Japan 2013-2022
- Premium Statistic Number of biosimilars approved by PMDA Japan 2010-2019
- Premium Statistic Number of in vitro diagnostics approved by PMDA Japan FY 2013-2022
- Basic Statistic Top drugs by DDD usage in Norway 2022
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
About the region
10
- Premium Statistic Number of biological drugs approved Japan 2012-2021
- Premium Statistic Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Basic Statistic Fuji Pharma's net sales FY 2013-2022
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2023
- Premium Statistic Noevir's operating income FY 2015-2019
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Number of approved new medical devices Japan FY 2013-2022, by year of submission
- Premium Statistic Number of newly approved medical devices Japan FY 2014-2022, by category
- Premium Statistic Number of approved generic medical devices Japan FY 2013-2022, by year of submiss
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2022
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Peru's major pharma import partners by value 2022
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Basic Statistic Value of pharmaceutical sales in Germany 2003-2021
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Revenue market share of acne treatments sold in Spain by company 2018
- Premium Statistic Pharmaceutical self-care companies in Sweden 2018, by sales value
- Premium Statistic Genomma Lab: headcount 2015-2019
- Premium Statistic Spending on pharmaceuticals in China 2018, by brand type
- Basic Statistic Value of pharmaceutical sales in Belgium 2004-2022
- Basic Statistic Value of pharmaceutical sales in Austria 2012-2021
Related statistics
10
- Premium Statistic Production value of pharmaceutical drugs Japan 2012-2021
- Premium Statistic Sawai Pharmaceutical's employee numbers 2012-2021
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2022
- Premium Statistic Number of patents in the pharmaceutical industry Japan 2022, by type
- Premium Statistic Fuji Pharma's R&D costs FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's revenue breakdown FY 2022, by region
- Basic Statistic Takeda Pharmaceutical's revenue FY 2013-2022
- Basic Statistic Nichi-Iko's sales revenue FY 2012-2021
- Premium Statistic Nichi-Iko's sales share of generics in Japan FY 2012-2021
- Premium Statistic Major drug manufacturers Japan FY 2020, by wholesalers' sales share
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- MorphoSys' research & development expenditure 2006-2022
- MorphoSys' revenue 2006-2022
- Sanofi's total assets 2007-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- MorphoSys' research & development expenditure 2006-2022
- MorphoSys' revenue 2006-2022
- Sanofi's total assets 2007-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
PMDA. (September 14, 2023). Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022 [Graph]. In Statista. Retrieved December 03, 2023, from https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/
PMDA. "Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022." Chart. September 14, 2023. Statista. Accessed December 03, 2023. https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/
PMDA. (2023). Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022. Statista. Statista Inc.. Accessed: December 03, 2023. https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/
PMDA. "Number of Pharmaceutical Drugs Approved by The Pharmaceuticals and Medical Devices Agency (Pmda) in Japan from Fiscal Years 2013 to 2022." Statista, Statista Inc., 14 Sep 2023, https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/
PMDA, Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022 Statista, https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/ (last visited December 03, 2023)
Number of pharmaceutical drugs approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal years 2013 to 2022 [Graph], PMDA, September 14, 2023. [Online]. Available: https://www.statista.com/statistics/827862/japan-pmda-number-approved-pharmaceutical-drugs/